Targeting cancer metabolism in the era of precision oncology

2021/12/03 by Zachary E. Stine, Zachary T. Schug, Joseph M. Salvino +1 · 9 citations
Biochemistry, Genetics and Molecular Biology · #Cancer, Hypoxia, and Metabolism #Epigenetics and DNA Methylation #RNA modifications and cancer

paper · pdf · doi:10.1038/s41573-021-00339-6

crossref issued 2021/12/03 · crossref published 2021/12/03 · crossref published-online 2021/12/03 · openalex publication_date 2021/12/03 · crossref created 2021/12/03 · crossref published-print 2022/02/01 · crossref deposited 2024/12/11 · openalex created_date 2025/10/10 · crossref indexed 2026/07/30 · openalex updated_date 2026/07/31

Cited by

• Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma
• Role of tumor microenvironment composition and metabolism in lymphoid malignancies and therapeutic strategies
• Acquired resistance in cancer: towards targeted therapeutic strategies
• De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma
• WNK1 signalling regulates amino acid transport and mTORC1 activity to sustain acute myeloid leukaemia growth
• Identification of metabolite biomarkers for pancreatic neuroendocrine tumours using a metabolomic approach
• The Role of One‐Carbon Metabolism in Cancer and Its Therapeutic Significance
• Thiosugar-functionalized gold(I)-NHC complexes as selective anticancer agents for potential targeted therapy
• Induction of a metabolic switch from glucose to ketone metabolism programs ketogenic diet-induced therapeutic vulnerability in lung cancer